Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model

被引:60
作者
Celli, Jonathan P. [1 ]
Rizvi, Imran [1 ,2 ]
Evans, Conor L. [1 ]
Abu-Yousif, Adnan O. [1 ]
Hasan, Tayyaba [1 ]
机构
[1] Harvard Univ, Sch Med, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA
基金
美国国家卫生研究院;
关键词
ovarian cancer; three-dimensional models; image processing; photodynamic therapy; carboplatin; INTRAPERITONEAL PHOTODYNAMIC THERAPY; PHASE-II TRIAL; IN-VIVO; EPITHELIAL ACINI; MALIGNANT BREAST; CELLS; CARCINOMATOSIS; FLUORESCENCE; SPHEROIDS; CULTURES;
D O I
10.1117/1.3483903
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Three-dimensional tumor models have emerged as valuable in vitro research tools, though the power of such systems as quantitative reporters of tumor growth and treatment response has not been adequately explored. We introduce an approach combining a 3-D model of disseminated ovarian cancer with high-throughput processing of image data for quantification of growth characteristics and cytotoxic response. We developed custom MATLAB routines to analyze longitudinally acquired dark-field microscopy images containing thousands of 3-D nodules. These data reveal a reproducible bimodal log-normal size distribution. Growth behavior is driven by migration and assembly, causing an exponential decay in spatial density concomitant with increasing mean size. At day 10, cultures are treated with either carboplatin or photodynamic therapy (PDT). We quantify size-dependent cytotoxic response for each treatment on a nodule by nodule basis using automated segmentation combined with ratiometric batch-processing of calcein and ethidium bromide fluorescence intensity data (indicating live and dead cells, respectively). Both treatments reduce viability, though carboplatin leaves micronodules largely structurally intact with a size distribution similar to untreated cultures. In contrast, PDT treatment disrupts micronodular structure, causing punctate regions of toxicity, shifting the distribution toward smaller sizes, and potentially increasing vulnerability to subsequent chemotherapeutic treatment. (C) 2010 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3483903]
引用
收藏
页数:10
相关论文
共 30 条
[1]  
Berek J S., 2003, Cancer Medicine, P1831
[2]   ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids [J].
Bigelow, CE ;
Mitra, S ;
Knuechel, R ;
Foster, TH .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :727-734
[3]   Putting tumours in context [J].
Bissell, MJ ;
Radisky, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :46-54
[4]  
Bissell MJ, 1999, CANCER RES, V59, p1757S
[5]   Ovarian Cancer [J].
Cho, Kathleen R. ;
Shih, Ie-Ming .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :287-313
[6]   Modelling glandular epithelial cancers in three-dimensional cultures [J].
Debnath, J ;
Brugge, JS .
NATURE REVIEWS CANCER, 2005, 5 (09) :675-688
[7]   Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures [J].
Debnath, J ;
Muthuswamy, SK ;
Brugge, JS .
METHODS, 2003, 30 (03) :256-268
[8]   The role of apoptosis in creating and maintaining luminal space with normal and oncogene-expressing mammary acini [J].
Debnath, J ;
Mills, KR ;
Collins, NL ;
Reginato, MJ ;
Muthuswamy, SK ;
Brugge, JS .
CELL, 2002, 111 (01) :29-40
[9]   Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo [J].
del Carmen, MG ;
Rizvi, I ;
Chang, YC ;
Moor, ACE ;
Oliva, E ;
Sherwood, M ;
Pogue, B ;
Hasan, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20) :1516-1524
[10]   In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging [J].
Evans, Conor L. ;
Rizvi, Imran ;
Hasan, Tayyaba ;
de Boer, Johannes F. .
OPTICS EXPRESS, 2009, 17 (11) :8892-8906